239 related articles for article (PubMed ID: 20847001)
41. CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.
Quach QL; Metz LM; Thomas JC; Rothbard JB; Steinman L; Ousman SS
Mult Scler; 2013 Dec; 19(14):1867-77. PubMed ID: 23736536
[TBL] [Abstract][Full Text] [Related]
42. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.
Li J; Wang Z; Hu S; Zhao X; Cao L
Immunol Lett; 2013; 154(1-2):42-8. PubMed ID: 23994430
[TBL] [Abstract][Full Text] [Related]
43. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
[TBL] [Abstract][Full Text] [Related]
44. [Function of CD4(+) CD25(+) regulatory T cells in Henoch-Schonlein purpura nephritis in children].
Shao X; Jiang C; Li Y; Jiang X; Xu H; Ying P; Qiu J; Lin J; Zheng S; Chang L; Huang Y
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):516-20. PubMed ID: 25224057
[TBL] [Abstract][Full Text] [Related]
45. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
[TBL] [Abstract][Full Text] [Related]
46. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
47. Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
Etesam Z; Nemati M; Ebrahimizadeh MA; Ebrahimi HA; Hajghani H; Khalili T; Frootan R; Zinoddini N; Jafarzadeh A
J Mol Neurosci; 2016 Sep; 60(1):94-101. PubMed ID: 27370539
[TBL] [Abstract][Full Text] [Related]
48. Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
Rodi M; Dimisianos N; de Lastic AL; Sakellaraki P; Deraos G; Matsoukas J; Papathanasopoulos P; Mouzaki A
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571060
[TBL] [Abstract][Full Text] [Related]
49. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH
PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517
[TBL] [Abstract][Full Text] [Related]
50. Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis.
Skundric DS; Cruikshank WW; Drulovic J
J Neuroinflammation; 2015 Apr; 12():78. PubMed ID: 25896927
[TBL] [Abstract][Full Text] [Related]
51. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
Kaur G; Goodall JC; Jarvis LB; Hill Gaston JS
Mol Immunol; 2010; 48(1-3):321-32. PubMed ID: 20688398
[TBL] [Abstract][Full Text] [Related]
52. Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis.
Yaldizli O; Kumar M; Vago S; Kreuzfelder E; Limmroth V; Putzki N
Eur Neurol; 2009; 62(6):321-6. PubMed ID: 19752558
[TBL] [Abstract][Full Text] [Related]
53. T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis.
Iorio R; Frisullo G; Nociti V; Patanella KA; Bianco A; Marti A; Mirabella M; Tonali PA; Batocchi AP
Clin Immunol; 2009 Apr; 131(1):70-83. PubMed ID: 19097824
[TBL] [Abstract][Full Text] [Related]
54. [Profiles of type 1 and type 2 T cells in chronic idiopathic thrombocytopenic purpura].
Wang TT; Zhao H; Ren H; Guo JH; Xu MQ; Yang RC; Han ZC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):669-73. PubMed ID: 16681922
[TBL] [Abstract][Full Text] [Related]
55. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
[TBL] [Abstract][Full Text] [Related]
56. T regulatory cells lacking CD25 are increased in MS during relapse.
Fransson M; Burman J; Lindqvist C; Atterby C; Fagius J; Loskog A
Autoimmunity; 2010 Dec; 43(8):590-7. PubMed ID: 20370571
[TBL] [Abstract][Full Text] [Related]
57. An increased ratio of Th2/Treg cells in patients with moderate to severe asthma.
Shi YH; Shi GC; Wan HY; Ai XY; Zhu HX; Tang W; Ma JY; Jin XY; Zhang BY
Chin Med J (Engl); 2013 Jun; 126(12):2248-53. PubMed ID: 23786933
[TBL] [Abstract][Full Text] [Related]
58. Dynamic DNA Methylation Changes of
Qiu Y; Zhu Y; Yu H; Zhou C; Kijlstra A; Yang P
Mediators Inflamm; 2018; 2018():9129163. PubMed ID: 30254507
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients.
Ghadiri N; Emamnia N; Ganjalikhani-Hakemi M; Ghaedi K; Etemadifar M; Salehi M; Shirzad H; Nasr-Esfahani MH
Gene; 2018 Jun; 659():109-117. PubMed ID: 29551498
[TBL] [Abstract][Full Text] [Related]
60. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
